XML 28 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business Segment Information (Notes)
 6 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Business Segment Information Business Segment Information
We report our financial information in four reportable business segments: Healthcare, Applied Sterilization Technologies, Life Sciences and Dental. Non-allocated operating costs that support the entire Company and items not indicative of operating trends are excluded from segment operating income.
Our Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. Our products and services range from infection prevention consumables and capital equipment, as well as services to maintain that equipment; to the repair of re-usable procedural instruments; to outsourced instrument reprocessing services. In addition, our procedural solutions also include single-use devices and capital equipment infrastructure used primarily in operating rooms, ambulatory surgery centers, endoscopy suites, and other procedural areas.
Our Applied Sterilization Technologies ("AST") segment is a third-party service provider for contract sterilization, as well as testing services needed to validate sterility services for medical device and pharmaceutical manufacturers. Our technology-neutral offering supports Customers every step of the way, from testing through sterilization.
Our Life Sciences segment provides a comprehensive offering of products and services that support pharmaceutical manufacturing, primarily for vaccine and other biopharma Customers focused on aseptic manufacturing. These solutions include a full suite of consumable products, equipment maintenance and specialty services, and capital equipment.
Our Dental segment provides a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems.
We disclose a measure of segment income that is consistent with the way management operates and views the business. The accounting policies for reportable segments are the same as those for the consolidated Company. Certain prior period costs were reallocated from the Healthcare segment to Corporate to conform with current year presentation. The prior period segment operating income measure has been recast for comparability.
For the three and six months ended September 30, 2022, revenues from a single Customer did not represent ten percent or more of the Healthcare, Applied Sterilization Technologies or Life Sciences segment revenues. Three Customers collectively and consistently account for approximately 40.0% of our Dental segment revenue. The percentage associated with these three Customers collectively in any one period may vary due to the buying patterns of these three Customers as well as other Dental Customers. These three Customers collectively accounted for approximately 40.1% and 42.1% of our Dental segment revenues for the three and six months ended September 30, 2022, respectively. These three Customers collectively accounted for approximately 40.6% and 39.5% of our Dental segment revenues for the three and six months ended September 30, 2021, respectively.
Additional information regarding our segments is included in our consolidated financial statements included in our Annual Report on Form 10-K for the year ended March 31, 2022, which was filed with the SEC on May 31, 2022.
Financial information for each of our segments is presented in the following table:
 Three Months Ended September 30, Six Months Ended September 30,
 2022202120222021
Revenues:
Healthcare $732,813 $744,134 $1,431,339 $1,346,951 
Applied Sterilization Technologies232,358 204,892 453,269 413,794 
Life Sciences125,768 132,327 257,975 253,798 
Dental109,578 115,632 214,425 150,864 
Total revenues$1,200,517 $1,196,985 $2,357,008 $2,165,407 
Segment operating income (loss):
Healthcare$165,337 $168,335 $321,834 $306,709 
Applied Sterilization Technologies110,384 99,789 219,699 201,716 
Life Sciences48,619 57,519 103,924 106,607 
Dental28,059 32,392 47,655 42,511 
Corporate(67,056)(79,497)(142,999)(156,771)
Total segment operating income$285,343 $278,538 $550,113 $500,772 
Less: Adjustments
Amortization of acquired intangible assets (1)
$93,859 $74,791 $187,786 $116,531 
Acquisition and integration related charges (2)
3,844 17,404 13,676 158,400 
Tax restructuring costs (3)
77 159 251 110 
(Gain) on fair value adjustment of acquisition related contingent consideration (1)
— — (3,100)— 
Net (gain) loss on divestiture of businesses (1)
899 (15)4,777 404 
Amortization of inventory and property "step up" to fair value (1)
2,452 69,486 4,089 94,276 
Restructuring charges (4)
62 210 89 224 
Goodwill impairment loss (5)
490,565 — 490,565 — 
Total income from operations$(306,415)$116,503 $(148,020)$130,827 
(1) For more information regarding our recent acquisitions and divestitures, refer to Note 2 titled, "Business Acquisitions and Divestitures" included in our Annual Report on Form 10-K for the year ended March 31, 2022, which was filed with the SEC on May 31, 2022.
(2) Acquisition and integration related charges include transaction costs and integration expenses associated with acquisitions.
(3) Costs incurred in tax restructuring.
(4) For more information regarding our restructuring efforts, refer to our Annual Report on Form 10-K for the year ended March 31, 2022, which was filed with the SEC on May 31, 2022.
(5) For more information regarding our goodwill impairment loss, see Note 17 to our consolidated financial statements titled, "Goodwill."
Additional information regarding our fiscal 2023 and fiscal 2022 revenue is disclosed in the following tables:
 Three Months Ended September 30, Six Months Ended September 30,
 2022202120222021
Healthcare:
Capital equipment$212,484 $202,405 $391,618 353,295
Consumables246,050 270,089 498,082 476,781
Service274,279 271,640 541,639 516,875 
Total Healthcare Revenues $732,813 $744,134 $1,431,339 $1,346,951 
Applied Sterilization Technologies Service Revenues$232,358 $204,892 $453,269 $413,794 
Life Sciences:
Capital equipment
$30,015 $34,186 $70,514 $66,931 
Consumables57,420 61,748 116,977 118,284 
Service38,333 36,393 70,484 68,583 
Total Life Sciences Revenues$125,768 $132,327 $257,975 $253,798 
Dental Revenues$109,578 $115,632 $214,425 $150,864 
Total Revenues$1,200,517 $1,196,985 $2,357,008 $2,165,407 
Three Months Ended September 30, Six Months Ended September 30,
2022202120222021
Revenues:
Ireland$16,995 $20,046 $35,171 $41,991 
United States871,981 852,497 1,706,082 1,531,747 
Other locations311,541 324,442 615,755 591,669 
Total Revenues
$1,200,517 $1,196,985 $2,357,008 $2,165,407